DAFNE, Study Group, Amiel, S, Beveridge , S, Bradley, Clare, Gianfrancesco , C, Heller , S, James, P, McKeown , N, Newton , D, Newton, L, Oliver, L, Reid, H, Roberts, S, Robson , S, Rollington , J, Scott, V, Speight, J, Taylor , C, Thompson, G, Turner, E and Wright, F (2002) Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomized controlled trial. British Medical Journal, 325
Full text access: Open
Objectives: To evaluate whether a course teaching flexible intensive insulin adjustment can improve both glycaemic control and quality of life in type 1 diabetes. Design: randomized design with participants either attending training immediately (immediate DAFNE) or acting as waiting list controls and attending "delayed DAFNE" training 6 months later. Setting: Secondary care diabetes clinics in three English health districts. Participants: 169 adults with type 1 diabetes and moderate or poor glycaemic control. Main outcome measures: Glycated haemoglobin (HbA 1c), severe hypoglycaemia, impact of diabetes on quality of life (ADDQoL). Results: At 6 months, HbA 1c was significantly better in immediate DAFNE patients (mean 8.4%) than in delayed DAFNE patients (9.4%) (t=6.1, P<0.0001). The impact of diabetes on dietry freedom was significantly improved in immediate DAFNE patients compared with delayed DAFNE patients (t= -5.4, P<0.0001), as was the impact of diabetes on overall quality of life (t = 2.9, P<0.01). General wellbeing and treatment satisfaction were also significantly improved, but severe hypoglycaemia, weight, and lipids remained unchanged. Improvements in "present quality of life" did not reach significance at 6 months but were significant by 1 year. Conclusion: Skills training promoting dietary freedom improved quality of life and glycaemic control in people with type 1 diabetes without worsening severe hypoglycaemia or cardiovascular risk. This approach has the potential to enable more people to adopt intensive insulin treatment and is worthy of further investigation.
This is a Submitted version This version's date is: 2002 This item is not peer reviewed
https://repository.royalholloway.ac.uk/items/b743cc26-5949-0a6e-274b-6af0d2ec4f61/4/
Deposited by Research Information System (atira) on 25-Jul-2012 in Royal Holloway Research Online.Last modified on 25-Jul-2012